Third Arc Bio logo

Third Arc Bio Funding & Investors

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pipeline of high-value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety.

thirdarcbio.com

Total Amount Raised: $165,000,000

Third Arc Bio Funding Rounds

  • Series A

    $165,000,000

    Series A Investors

    Cormorant Asset Management
    Hillhouse Investment
    Vida Ventures
    Logos Capital
    BVF Partners
    abrdn
    Janus Henderson Investors
    AbbVie
    Freepoint Capital Group
    Marshall Wace
    T. Rowe Price
    Goldman Sachs Alternatives
    Foresite Capital
    Omega Fund Management
Funding info provided by Diffbot.